MANAGEMENT AND OUTCOME OF ATOPIC DERMATITIS IN PRIMARY HEALTH CARE IN LOW INCOME COUNTRIES : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/85nf6124Keywords:
Dermatitis atopic, primary health care, management, outcomeAbstract
Background: Atopic dermatitis is a chronic inflammatory skin disorder that is complicated and recurring. It usually first appears in early childhood and might persist throughout maturity.
Aims : This systematic review is to review the management and outcome of atopic dermatitis in primary health care in low income countries.
Methods: This study demonstrated compliance with all requirements by means of a comparison with the standards established by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020. Thus, the specialists were able to guarantee that the research was as current as feasible. Publications released between 2014 and 2024 were considered for this search strategy. This was accomplished by utilizing a number of distinct online reference sites, including Pubmed, ScienceDirect, and SagePub. It was determined that reviews, previously published works, and partially completed works would not be included.
Result: In the PubMed database, the results of our search brought up 539 articles, whereas the results of our search on SCIENCE DIRECT brought up 9.462 articles, our search on SAGEPUB brought up 1.264 articles. The results of the search conducted for the last year of 2014 yielded a total 425 articles for PubMed, 5.474 articles for SCIENCE DIRECT and 613 articles for SAGEPUB. In the end, we compiled a total of 5 papers, 3 of which came from PubMed, 1 of which came from SCIENCE DIRECT and 1 of which came from SAGEPUB. We included five research that met the criteria.
Conclusion: In summary, atopic dermatitis is still a major global public health problem, especially for women and young children as well as in high-income nations. It is important to recognize the profound effects on patients, their families, and economies as well as the financial ramifications.
References
Young TK, Glickk AF, Yin HS, Kolla AM, Velazquez JJ, Nicholson J, et al. Management of Pediatric Atopic Dermatitis by Primary Care Providers: A Systematic Review. Acad Pediatr. 2021;21(8):1318–27.
Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284–93.
Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26–30.
Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kaabashima K. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. J Invest Dermatol. 2017;137(1):18–25.
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality an update from the global burden of disease study 2013. JAMA Dermatol. 2017 May 1;153(5):406–12.
Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. Journal of Experimental Medicine. 2013 Dec;210(13):2939–50.
Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab. 2015;
Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review . BJD. 2013;
Bylund S, Von Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: A systematic review. Vol. 100, Acta Dermato-Venereologica. Medical Journals/Acta D-V; 2020. p. 320–9.
Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;
Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.
Fletcher MJ, Tsiligianni I, Kocks JWH, Cave A, Chunhua C, Sousa JC de, et al. Improving primary care management of asthma: do we know what really works Vol. 30, npj Primary Care Respiratory Medicine. Nature Research; 2020.
Rea CJ, Tran KD, Jorina M, Wenren LM, Hawryluk EB, Toomey SL. A Randomized Controlled Trial of an Eczema Care Plan. Acad Pediatr. 2018;18(7):789–96.
Hammer-Helmich L, Linneberg A, Thomsen SF, Glumer C. Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children. Scand J Public Health. 2014;42(2):120–7.
Abdullah AH, Nathan Am, Jayanath S, Kwan Z, Azanan MS, Hng SY, et al. Poor sleep quality in children with atopic dermatitis and its effects on behavior: A multicenter cross-sectional study from a low-middle-income country. Pediatr Int. 2023;15473.
Nagata A, Kazi T, Akter Z, Nody FA, Khan MS, Shahriar ASM, et al. The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh. Int J Environ Res Public Health. 2021;11593.
Stuart B, Rumbsby K, Santer M, Ridd MJ, Francis NA, Chorozoglou M, et al. Feasibility of weekly participant-reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema). Trials. 2018;582.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ronald Yulianto, Ellen Aristika Gunawan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
